Economic Burden of Prostate Cancer

Speaker: Dr. Alice Dragomir
Original Date: Tuesday, September 9, 2014

Join Dr. Alice Dragomir as she presents "Economic Burden of Prostate Cancer."
During this webinar, Dr. Alice Dragomir will be discusses the background and endpoints of a study looking at the cost of managing prostate cancer for patients, their circle of care and society.  Dr. Dr. Dragomir will respond to any questions about the survey, “Estimation of out-of-pocket costs incurred by patients with prostate cancer”, including:

  • How much prostate cancer patients spend on treatments and services related to their cancer throughout the disease
  • The economic burden of the disease
  • The role of private or public health insurance in covering these costs
  • The impact of costs on overall quality of life

Speaker – Dr. Alice Dragomir

Dr. Dragomir is an Assistant Professor at McGill University, Department of Surgery, Division of Urology and a Scientist in Health Economics and Outcomes Research at the Research Institute of McGill University Health Center. Her current research is mainly focused on Health Economics and Outcomes Research of prostate cancer.

Dr. Dragomir is an economist and biostatistician with a doctoral degree in pharmacoepidemiology and pharmacoeconomics, from the University of Montreal, Canada. In the last 12 years, she has worked in academic research in pharmacoepidemiology, health economics and biostatistics. She was involved in research projects focused on the evaluation of health outcomes and health economics related to different treatment strategies, adherence to treatments, and disease modelling in several fields, such as: hypertension, dyslipidemia, cardiovascular diseases, osteoporosis, mental health diseases, colorectal and prostate cancer. Her research represents a valuable tool for decision-makers and clinician leaders when evaluating the clinical and economic impacts of innovative treatments.

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Help us take the first steps toward prevention. Donate Now

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Click here for news archive